tags

CIRS Group has summarized the latest global cosmetic regulatory developments of September 2026 to help enterprises gain a comprehensive view of global regulatory trends.

CIRS Group has compiled and summarized the latest global cosmetics regulatory developments in August 2026.

Learn what brands need to know when launching sunscreens in the EU, UK, and China. This practical guide covers sunscreen classification, permitted UV filters, SPF and UVA testing requirements, labeling, and key regulatory differences to help companies plan compliant global sunscreen launches and avoid costly delays.

Not all cosmetic test reports are created equal: some are rejected by regulators, and some aren’t internationally recognized. Choosing the wrong laboratory can delay your product launch or even block market entry entirely. This article explains the differences between CMA, CNAS, and ISO 17025 accreditation, why they matter for cosmetic testing in China, and how to select the right lab for regulatory compliance.

On May 29, 2026, China’s National Medical Products Administration (NMPA) released eight testing methods to be incorporated into the corresponding chapters of the Safety and Technical Standards for Cosmetics (2015 Edition).

On April 13, 2026, China’s National Medical Products Administration (NMPA) carried out the fourth dynamic adjustment to the Inventory of Existing Cosmetic Ingredients in China, involving a total of 50 records. For certain ingredients revised in IECIC I, the updated names differ from those currently listed in the EU Cosmetic Ingredient Catalogue ((EU) 2025/1175) and the US INCI database.

In the cosmetics industry, INCI names and CAS numbers are regarded as the "birth certificates" for new ingredients. These identifiers not only establish the identity of the ingredients but also facilitate their recognition and communication in the global market. This article explores the definitions, application processes, and international market applications of INCI names and CAS numbers, aiming to help cosmetic companies better understand their significance.

Starting March 1, 2026, a total of 12 cosmetic testing methods will be officially implemented in China. CIRS Group has summarized them for reference.

In February 2026, the National Medical Products Administration, along with the Medical Products Administrations of Guangxi Zhuang Autonomous Region, Hunan Province, and Beijing, issued announcements regarding cosmetic supervision and sampling inspections. A total of 71 batches of products were found to be non-compliant. This summary of the announcements aims to help enterprises stay informed of evolving regulatory trends and strengthen their quality management and compliance awareness.

This article compiles and summarizes the latest developments in cosmetics regulations as of January 2026, including domestic China industry news, newly issued regulations, updates to relevant standards and policies, and regulatory requirements, as well as global regulatory trends in the cosmetics sector. It aims to assist enterprises in ensuring compliance and keeping up with global cosmetics regulatory trends.